Panama launched a plan to become a regional hub for the pharmaceutical and medical device industry.
The Ministry of Health (Minsa) presented the initiative with the aim of attracting investment and strengthening the country's health system.
The proposal is based on six pillars: health logistics, clinical trials, domestic drug manufacturing, medical device manufacturing, human capital, and technical cooperation. These pillars will shape the roadmap to boost the sector's competitiveness in the coming years.
Health Minister Fernando Boyd Galindo led the presentation event for the initiative, where he underscored the need to strengthen the capacities of Panama's health system.
Boyd Galindo also reported on the actions the Minsa is carrying out to meet the population's health needs, framing the initiative as a tool to open up investment and economic growth opportunities linked to the sector.
The national head of Pharmacy and Drugs, Uriel Pérez, explained in turn that one of the central objectives is to develop regulatory, logistics, and technical proposals.
Those proposals, he said, seek to optimize access to medicines and medical devices through efficient regional-level distribution.
Pérez noted that pharmaceutical logistics is not limited to moving goods. The official stressed that the real challenge lies in guaran…
AI Brief
Your highlights
A worker packs boxes of injectable solution for diabetes treatment at a pharmaceutical plant. (Illustrative image Infobae)
Panama launched a plan to become a regional hub for the pharmaceutical and medical device industry. The Ministry of Health (Minsa) presented the initiative with the aim of attracting investment and strengthening the country's health system. The proposal is based on six pillars, consisting of health logistics, clinical trials, domestic drug manufacturing, medical device manufacturing, human capital, and technical cooperation. These axes will chart the roadmap to boost the sector's competitiveness in the coming years.
Health Minister Fernando Boyd Galindo led the presentation of the initiative, where he underscored the need to strengthen the capacities of Panama's health system. Boyd Galindo also reported on the actions the Minsa is carrying out to meet the population's health needs, framing the initiative as a tool to open up investment opportunities and economic growth linked to the sector.
A thyroid medication bottle and several tablets rest on a pharmaceutical laboratory table. (Illustrative image Infobae)
Uriel Pérez, the national head of Pharmacy and Drugs, explained in turn that one of the central objectives is to develop regulatory, logistics, and technical proposals. Those proposals, he said, seek to optimize access to medicines and medical devices through efficient regional-level distribution.
Pérez noted that pharmaceutical logistics is not limited to moving goods. The official stressed that the real challenge lies in ensuring that health products arrive on time and under proper conditions of quality and traceability.
In detailing what Panama's plan to become a pharmaceutical hub consists of, it was explained that it is a Ministry of Health strategy with six pillars (logistics, clinical trials, drug and medical device manufacturing, human capital, and technical cooperation) that seeks to modernize health regulation, streamline licensing, and position the country as a regional distribution center for health products.
The pharmaceutical logistics strategy rests on three axes defined by traceability, quality, and reduction of institutional response times. The National Directorate of Pharmacy and Drugs pushed legislative and regulatory changes to modernize the sector's processes. Courtesy
Pérez indicated that the National Directorate of Pharmacy and Drugs has already pushed legislative and regulatory adjustments, with more than 20 resolutions published to modernize the sector's processes. Among the goals set is shortening the timeframes for obtaining operating licenses and good storage practice certifications. The national head of Pharmacy and Drugs specified that this objective will be met without compromising national and international quality standards.
Katia Banda, the national director of Medical Devices, explained at the time that the initiative is the result of coordinated work that began in May 2025, a process in which several public and private institutions linked to the health sector participated. Banda thanked the sectors involved in building the proposal for their commitment, acknowledging the support of health authorities for including medical devices as a fundamental component of the plan. The official highlighted that this incorporation made it possible to consolidate a comprehensive proposal, with projection toward the rest of the region. The joint work between the State and the private sector thus became the operational foundation of the initiative.
The joint work between the State and the private sector became the operational foundation of the initiative. (Photo: Shutterstock)
With this plan, the information released by the health institutions agrees in pointing out that the Ministry of Health seeks to simultaneously strengthen the country's logistics, regulatory, and industrial capacities. The health ministry, they stated, is betting that this combination will improve the population's access to medicines and medical devices. The agency projects that these advances will allow Panama to consolidate itself as a regional pharmaceutical and medical device hub.
The roadmap defined by the six pillars will now be monitored by health authorities and the private actors who participated in its design, the organizers said.